- About the Study
- The purpose of this study is to evaluate the safety and efficacy of an oral investigational drug when given to patients with vitiligo. Your participation will allow doctors and researchers to learn more about the investigational drug being evaluated in this research study.
- What does the study involve?
- You will take your assigned study drug (investigational drug or placebo—something that looks like the investigational drug but has no effect on the body) once daily during this period, which lasts for 48 weeks. Both the investigational drug and placebo are tablets taken orally (by mouth).
- Who can participate?
- You must be at least 12 with a clinical diagnosis of non segmental vitiligo. Must have vitiligo on both your face and body.
- Where is the study taking place?
- The study is being conducted at our Weston and Hollywood offices.
- Is compensation provided?
- Yes, you will be compensated for your participation. Travel reimbursement and meals are not provided.